Spain
· Delayed Price · Currency is EUR CLERHP Estructuras Statistics
Total Valuation
BME:CLR has a market cap or net worth of EUR 49.83 million. The enterprise value is 58.13 million.
| Market Cap | 49.83M |
| Enterprise Value | 58.13M |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:CLR has 14.53 million shares outstanding. The number of shares has increased by 4.79% in one year.
| Current Share Class | 14.53M |
| Shares Outstanding | 14.53M |
| Shares Change (YoY) | +4.79% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.83M |
Valuation Ratios
The trailing PE ratio is 32.65 and the forward PE ratio is 9.24.
| PE Ratio | 32.65 |
| Forward PE | 9.24 |
| PS Ratio | 2.75 |
| PB Ratio | 4.89 |
| P/TBV Ratio | 5.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.72, with an EV/FCF ratio of -12.87.
| EV / Earnings | 19.47 |
| EV / Sales | 3.20 |
| EV / EBITDA | 11.72 |
| EV / EBIT | 14.21 |
| EV / FCF | -12.87 |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 1.02.
| Current Ratio | 1.29 |
| Quick Ratio | 0.51 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | -2.30 |
| Interest Coverage | 2.70 |
Financial Efficiency
Return on equity (ROE) is 17.98% and return on invested capital (ROIC) is 13.76%.
| Return on Equity (ROE) | 17.98% |
| Return on Assets (ROA) | 4.77% |
| Return on Invested Capital (ROIC) | 13.76% |
| Return on Capital Employed (ROCE) | 19.39% |
| Revenue Per Employee | 141,780 |
| Profits Per Employee | 23,327 |
| Employee Count | 128 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 0.16 |
Taxes
In the past 12 months, BME:CLR has paid 752,559 in taxes.
| Income Tax | 752,559 |
| Effective Tax Rate | 32.75% |
Stock Price Statistics
The stock price has decreased by -26.22% in the last 52 weeks. The beta is 0.83, so BME:CLR's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -26.22% |
| 50-Day Moving Average | 3.49 |
| 200-Day Moving Average | 4.06 |
| Relative Strength Index (RSI) | 49.51 |
| Average Volume (20 Days) | 15,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:CLR had revenue of EUR 18.15 million and earned 2.99 million in profits. Earnings per share was 0.21.
| Revenue | 18.15M |
| Gross Profit | 14.33M |
| Operating Income | 4.09M |
| Pretax Income | 2.30M |
| Net Income | 2.99M |
| EBITDA | 4.96M |
| EBIT | 4.09M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 2.18 million in cash and 10.38 million in debt, giving a net cash position of -8.20 million or -0.56 per share.
| Cash & Cash Equivalents | 2.18M |
| Total Debt | 10.38M |
| Net Cash | -8.20M |
| Net Cash Per Share | -0.56 |
| Equity (Book Value) | 10.19M |
| Book Value Per Share | 0.69 |
| Working Capital | 13.52M |
Cash Flow
In the last 12 months, operating cash flow was -2.19 million and capital expenditures -2.33 million, giving a free cash flow of -4.51 million.
| Operating Cash Flow | -2.19M |
| Capital Expenditures | -2.33M |
| Free Cash Flow | -4.51M |
| FCF Per Share | -0.31 |
Margins
Gross margin is 78.95%, with operating and profit margins of 22.54% and 16.45%.
| Gross Margin | 78.95% |
| Operating Margin | 22.54% |
| Pretax Margin | 12.66% |
| Profit Margin | 16.45% |
| EBITDA Margin | 27.33% |
| EBIT Margin | 22.54% |
| FCF Margin | n/a |
Dividends & Yields
BME:CLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.79% |
| Shareholder Yield | n/a |
| Earnings Yield | 5.99% |
| FCF Yield | -9.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:CLR has an Altman Z-Score of 1.36 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.36 |
| Piotroski F-Score | 4 |